Penn Medicine State of the Art Heart Failure Course 2022 (Videos + PDFs)

Advanced Heart Failure, Cardiogenic Shock, Transplantation & Mechanical Circulatory Support Update

Overview

Penn Medicine State of the Art Heart Failure Course 2022 is a comprehensive cardiovascular education program providing an in-depth review of contemporary heart failure management, advanced therapies, transplant cardiology, cardiogenic shock, mechanical circulatory support, and guideline-directed medical therapy (GDMT).

Held on October 21–22, 2022, at the Arthur H. Rubenstein Auditorium in Philadelphia and online, this hybrid conference brings together leading heart failure cardiologists, interventional cardiologists, electrophysiologists, cardiothoracic surgeons, genetic specialists, advanced practice providers, and members of multidisciplinary heart failure teams.

The course focuses on implementing the newly updated ACC/AHA Heart Failure Guidelines, optimizing evidence-based therapies, identifying patients who may benefit from advanced interventions, and improving outcomes through multidisciplinary care models. Through case-based learning, expert panel discussions, debates, and a unique mock transplant and ventricular assist device (VAD) selection committee, participants gain practical insights into the management of both routine and complex heart failure patients.

This educational package includes 31 video lectures and 33 PDF presentations, making it an outstanding resource for clinicians involved in heart failure and cardiovascular care.

Course Highlights

• 31 Expert-Led Video Lectures
• 33 Downloadable PDF Presentations
• ACC/AHA Heart Failure Guideline Updates
• Heart Failure with Reduced Ejection Fraction (HFrEF)
• Heart Failure with Preserved Ejection Fraction (HFpEF)
• Cardiogenic Shock Management
• Heart Transplantation Education
• Ventricular Assist Device (VAD) Training
• Cardiac Amyloidosis & Hypertrophic Cardiomyopathy
• Advanced Heart Failure Team-Based Care

Learning Objectives

Upon completion of this course, participants will be able to:

• Apply contemporary ACC/AHA heart failure management guidelines.
• Implement guideline-directed medical therapy (GDMT) effectively.
• Optimize use of SGLT2 inhibitors and soluble guanylate cyclase stimulators.
• Recognize indications for advanced heart failure therapies.
• Identify patients who may benefit from heart transplantation or VAD support.
• Evaluate evidence-based therapies for HFpEF and HFrEF.
• Diagnose and manage amyloid and hypertrophic cardiomyopathies.
• Utilize remote monitoring technologies in heart failure care.
• Understand indications for ICDs, CRT, and cardiac contractility modulation.
• Assess the cardiovascular effects of COVID-19 and cancer therapies.
• Apply genetic testing in inherited cardiomyopathies.
• Improve multidisciplinary heart failure program referrals and care coordination.

Major Topics Covered

Guideline-Directed Medical Therapy (GDMT)

The course provides a detailed review of contemporary pharmacologic treatment strategies for heart failure.

Topics Include

• SGLT2 inhibitors
• ARNI therapy
• Beta-blockers
• Mineralocorticoid receptor antagonists (MRAs)
• Soluble guanylate cyclase stimulators
• Comprehensive GDMT optimization

Faculty emphasize practical strategies to increase utilization of all four foundational medication classes for patients with HFrEF.

Heart Failure with Reduced Ejection Fraction (HFrEF)

A major focus is placed on evidence-based management of systolic heart failure.

Covered Topics

• HFrEF diagnosis
• Medication optimization
• Device therapy
• Prognostic assessment
• Advanced treatment pathways
• Long-term management strategies

Participants learn how to improve outcomes using current guideline recommendations.

Heart Failure with Preserved Ejection Fraction (HFpEF)

The course reviews recent advances in HFpEF management.

Topics Include

• HFpEF diagnosis
• Risk factor modification
• Emerging therapies
• SGLT2 inhibitor evidence
• Clinical trial updates
• Multidisciplinary management

These sessions address one of the fastest-growing areas in cardiovascular medicine.

Cardiogenic Shock

Specialized lectures focus on the diagnosis and management of cardiogenic shock.

Topics Include

• Shock classification
• Hemodynamic assessment
• Temporary mechanical support
• Revascularization strategies
• Critical care management
• Shock team approaches

Participants gain practical knowledge for managing critically ill cardiovascular patients.

Heart Transplantation

Advanced heart failure therapies receive extensive coverage throughout the course.

Topics Include

• Transplant candidacy
• Selection criteria
• Clinical evaluation
• Risk assessment
• Psychosocial considerations
• Post-transplant outcomes

A unique feature is the mock heart transplant selection committee discussion, providing real-world insight into transplant decision-making.

Ventricular Assist Devices (VADs)

The course offers comprehensive education on mechanical circulatory support.

Covered Topics

• LVAD indications
• Patient selection
• Bridge-to-transplant strategies
• Destination therapy
• Complication management
• Long-term outcomes

Participants learn how multidisciplinary teams evaluate and manage VAD candidates.

Cardiac Amyloidosis & Hypertrophic Cardiomyopathy

The program reviews important causes of non-ischemic heart failure.

Topics Include

• Transthyretin amyloidosis (ATTR)
• AL amyloidosis
• Hypertrophic cardiomyopathy
• Advanced imaging
• Emerging therapies
• Prognostic assessment

Faculty discuss evolving treatment options that have transformed patient outcomes.

Structural Heart Disease & Valve Interventions

The course reviews structural interventions frequently encountered in heart failure management.

Topics Include

• Transcatheter Aortic Valve Replacement (TAVR)
• Mitral valve edge-to-edge repair
• Valvular heart disease
• Patient selection
• Outcomes assessment

These therapies increasingly play a central role in advanced heart failure care.

Device Therapy

Advanced cardiac devices are reviewed in detail.

Topics Include

• Implantable cardioverter-defibrillators (ICDs)
• Cardiac resynchronization therapy (CRT)
• Biventricular pacing
• Cardiac contractility modulation
• Remote monitoring technologies

Participants learn how to optimize device therapy to improve survival and quality of life.

Genetics & Cardiomyopathy

The symposium highlights the growing importance of cardiovascular genetics.

Topics Include

• Genetic cardiomyopathies
• Family screening
• Genetic testing indications
• Inherited heart failure syndromes
• Precision medicine approaches

These sessions demonstrate how genetics increasingly guides diagnosis and treatment.

Cardio-Oncology & COVID-19

The conference also addresses emerging cardiovascular challenges.

Covered Topics

• Cardiotoxicity from cancer therapies
• Chemotherapy-related heart failure
• COVID-19 cardiac complications
• Long-term cardiovascular effects
• Monitoring and prevention strategies

These discussions provide practical guidance for managing complex patient populations.

Multidisciplinary Heart Failure Care

A recurring theme throughout the program is team-based management.

Topics Include

• Heart failure clinics
• Care coordination
• Advanced practice providers
• Social work integration
• Palliative care
• Patient-centered care models

Participants learn when referral to specialized heart failure programs is appropriate.

Educational Features

✔ Comprehensive heart failure guideline update

✔ Advanced heart failure management strategies

✔ Heart transplantation education

✔ Ventricular assist device training

✔ Cardiogenic shock management

✔ Amyloidosis and cardiomyopathy updates

✔ Structural heart intervention reviews

✔ Device therapy optimization

✔ Multidisciplinary team-based learning

✔ Case-based discussions and expert panels

Who Should Attend?

This course is ideal for:

• Cardiologists
• Advanced Heart Failure Specialists
• Heart Transplant Cardiologists
• Interventional Cardiologists
• Electrophysiologists
• Cardiothoracic Surgeons
• Internal Medicine Physicians
• Family Medicine Physicians
• Critical Care Physicians
• Nurse Practitioners
• Physician Assistants
• Fellows and Residents

Why This Course Stands Out

✔ Focuses on newly updated ACC/AHA Heart Failure Guidelines

✔ Strong emphasis on practical clinical application

✔ Covers both medical and device therapies

✔ Unique transplant and VAD selection committee simulation

✔ Includes advanced heart failure and transplant education

✔ Reviews emerging therapies and clinical trials

✔ Multidisciplinary faculty and real-world case discussions

✔ Excellent resource for board preparation and clinical updates

✔ Addresses both common and rare heart failure etiologies

✔ Applicable across inpatient and outpatient cardiovascular care

Topics:

• Acute Shock and Shock Team.mp4
• Acute Shock and Shock Team.pdf
• Advanced Therapies Selection Meeting ‘The Chosen Ones’.mp4
• Advanced Therapies Selection Meeting ‘The Chosen Ones’.pdf
• Amyloid – ‘Gumming up the Works’.mp4
• Amyloid – ‘Gumming up the Works’.pdf
• Cardiac Effects of COVID – ‘Pandemic Palpitations’.mp4
• Cardiac Effects of COVID – ‘Pandemic Palpitations’.pdf
• Cardio-Oncology ‘Good Drugs Gone Bad’.mp4
• Cardio-Oncology ‘Good Drugs Gone Bad’.pdf
• Case 1.mp4
• Case 1.pdf
• Case 2.mp4
• Case 2.pdf
• Case 3.mp4
• Case 3.pdf
• Case 4.mp4
• Case 4.pdf
• Comorbidites in Heart Failure.mp4
• Comorbidites in Heart Failure.pdf
• Debate – VAD Outcomes are as Good as Heart Transplant ‘It’s a Wash’.pdf
• Debate – VAD Outcomes are as Good as Heart Transplant “It’s a Wash”.mp4
• Debate – VAD Outcomes are as Good as Heart Transplant “It’s a Wash”.pdf
• Devices to Help the Failing Heart – ‘Just a Lttle Clip’.mp4
• Devices to Help the Failing Heart – ‘Just a Lttle Clip’.pdf
• EP and Heart Failure – ‘Keeping the Beat’.mp4
• EP and Heart Failure – ‘Keeping the Beat’.pdf
• Genetic Dilated Cardimyopathy – ‘It’s in the Genes’.pdf
• Heart Transplant – ‘Change of Heart’.mp4
• Heart Transplant – ‘Change of Heart’.pdf
• HF22_Brochure_v13.pdf
• HFpEF – Finally Something to do.pdf
• Hypertrophic Cardiomyopathy.pdf
• Keynote- Cardiogenic Shock- Principles, Progress and Future Prospects.mp4
• Keynote- Cardiogenic Shock- Principles, Progress and Future Prospects.pdf
• KEYNOTE- The New AHA ACC HFSA Heart Failure Guidelines.mp4
• KEYNOTE- The New AHA ACC HFSA Heart Failure Guidelines.pdf
• Living with Heart Failure (or MCS or Transplant) – ‘No Pulse No Problem’.mp4
• Living with Heart Failure (or MCS or Transplant) – ‘No Pulse No Problem’.pdf
• Mechanical Circulatory Support – ‘Go with the Continuous Flow’.mp4
• Mechanical Circulatory Support – ‘Go with the Continuous Flow’.pdf
• New Heart Failure Guidelines.mp4
• New Heart Failure Guidelines.pdf
• New Technologies That Might Just Work.mp4
• New Technologies That Might Just Work.pdf
• Novel Drugs.mp4
• Novel Drugs.pdf
• Overcoming Barriers to Advanced Therapies.mp4
• Overcoming Barriers to Advanced Therapies.pdf
• Panel Discussion with Q&A.mp4
• Pulmonary Hypertension and Right Ventricular Failure.mp4
• Pulmonary Hypertension and Right Ventricular Failure.pdf
• Remote Monitoring – ‘Keeping my eye on you’.mp4
• Remote Monitoring – ‘Keeping my eye on you’.pdf
• Revascularization.mp4
• Revascularization.pdf
• Sarcoid – ‘My Heart is on Fire’.mp4
• Sarcoid – ‘My Heart is on Fire’.pdf
• SGLT-2 Inhibitors and Vericiguat ‘How Sweet it is!’.mp4
• SGLT-2 Inhibitors and Vericiguat ‘How Sweet it is!’.pdf
• Systolic Heart Failure – How to Achieve Myocardial Recovery Panel Discussion with Q&A 1.mp4
• Systolic Heart Failure – How to Achieve Myocardial Recovery Panel Discussion with Q&A 2.mp4
• Valve Surgery.mp4
• Valve Surgery.pdf